A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: A pilot study of relapse prevention

Journal of Psychiatry and Neuroscience

Volumn 40, Issue 4, 2015, Pages 224-231

  Puigdemont, Dolors ^a   Portella, Maria J ^a   Pérez Egea, Rosario ^a   Molet, Joan ^b   Gironell, Alexandre ^b   de Diego Adeliño, Javier ^a   Martín, Anna ^a   Rodríguez, Rodrigo ^b   Àlvarez, Enric ^a   Artigas, Francesc ^c   Pérez, Víctor ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INST D INVESTIGACIONS B   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BRAIN DEPTH STIMULATION; CINGULATE GYRUS; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DEPRESSION; ELECTROSTIMULATION; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; IMPLANTABLE NEUROSTIMULATOR; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PILOT STUDY; SCORING SYSTEM; CONTROLLED STUDY; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE BLIND PROCEDURE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; TREATMENT OUTCOME;

ADULT; CROSS-OVER STUDIES; DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84931423992     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130295     Document Type: Article

References (23)

1. World Health Organization (WHO). The global burden of disease: 2004 update. Geneva, Switzerland: WHO, 2008. Available: http:// goo.gl/eQqphv (accessed 2015 Jan. 14).
2. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-17.
3. Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci 2011;34:289-307.
4. Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011;168:502-10.
5. Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012;69:150-8.
6. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651-60.
7. Puigdemont D, Perez-Egea R, Portella MJ, et al. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. Int J Neuropsychopharmacol 2012;15:121-33.
8. Portella MJ, Puigdemont D, Alvarez E, et al. Update on deep brain stimulation for treatment-resistant depression. Curr Psychiatry Rev 2012;8:175-82.
9. Lozano AM, Mayberg HS, Giacobbe P, et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008;64:461-7.
10. Schlaepfer TE, Cohen MX, Frick C, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008;33:368-77.
11. Bewernick BH, Hurlemann R, Matusch A, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010;67:110-6.
12. Malone DA Jr, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009;65:267-75.
13. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003;23:4315-23.
14. Mercado R, Constantoyannis C, Mandat T, et al. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation. Mov Disord 2006;21:1457-61.
15. Dougherty DD, Carpenter LL, Bhati MT, et al. A randomized sham-controlled trial of DBS of the VC/VS for treatment-resistant depression. Society of Biological Psychiatry 67th Annual Scientific Convention. 2012 May 3-5; Philadelphia, Pa. Abstract available: http://goo.gl/PGTpo (accessed 2015 Jan. 14).
16. Groenewegen HJ, Uylings HB. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 2000;126:3-28.
17. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001;24:167-202.
18. Seminowicz DA, Mayberg HS, McIntosh AR, et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004;22:409-18.
19. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacoly 2010;35:192-216
20. Ongür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000;10:206-19
21. Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci 2012;16:61-71.
22. Vedam-Mai V, van Battum EY, Kamphuis W, et al. Deep brain stimulation and the role of astrocytes. Mol Psychiatry 2012;17:124-31, 15.
23. Riva-Posse P, Holtzheimer PE, Garlow SJ, et al. Practical considerations in the development and refinement of subcallosal cingulate white matter deep brain stimulation for treatment-resistant depression. World Neurosurg 2013;80:S27.e25-34.